Skip to main content
Mark Hlatky, MD, Cardiology, Stanford, CA, Stanford Health Care

MarkA.HlatkyMD

Cardiology • Stanford, CA

Adult Congenital Heart Disease

Professor, Health Research & Policy, Stanford University Medical Center

Join to view full profile

Dr. Hlatky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hlatky's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1981 - 1983
  • University of Arizona College of Medicine-Tucson
    University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1976 - 1979
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1976

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1978 - Present
  • CA State Medical License
    CA State Medical License 1979 - 2024
  • NC State Medical License
    NC State Medical License 1981 - 1998
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Adverse Pregnancy Outcomes with Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women  
    Mark A Hlatky, Joann E Manson, JAMA Cardiology
  • Reduced Risk of Gastrointestinal Bleeding Associated with Proton Pump Inhibitor Therapy in Patients Treated with Dual Antiplatelet Therapy After Myocardial Infarction  
    Mark Hlatky, MD, European Heart Journal
  • Mini Focus on Diabetes Original Investigation Hypoglycemia and Elevated Troponin in Patients with Diabetes and Coronary Artery Disease  
    Brendan M Everett, Mark A Hlatky, Robert L Frye, Trevor J Orchard, Deepak L Bhatt, ScienceDirect
  • Join now to see all

Lectures

  • Debate Con: PCSK9 Inhibitors: Is the Benefit Worth the Cost? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Pre-eclampsia: a Vascular Disease Across the Lifespan 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Other

Press Mentions

  • Vitamin D and Statins: Supplements May Not Help Ease Muscle Pain, Side Effects
    Vitamin D and Statins: Supplements May Not Help Ease Muscle Pain, Side EffectsNovember 29th, 2022
  • Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITAL
    Vitamin D Doesn’t Reduce Statin-Associated Muscle Symptoms: VITALNovember 25th, 2022
  • Vitamin D Ruled Out as Solution to Statin Intolerance
    Vitamin D Ruled Out as Solution to Statin IntoleranceNovember 23rd, 2022
  • Join now to see all

Grant Support

  • Improved Estimates Of The Comparative Treatment Effects Of CABG And PCINational Heart, Lung, And Blood Institute2009–2010
  • Economic Outcomes Of Treatment Strategies In Bar1-2National Heart, Lung, And Blood Institute2000–2006
  • COST And Quality Of Life Outcomes After PTCA Or CABGNational Heart, Lung, And Blood Institute1997–2000
  • Clinical Research Training ProgramNational Heart, Lung, And Blood Institute1999
  • Cardiac Arrhythmia PORTAgency For Healthcare Research And Quality1994–1998

Professional Memberships

Hospital Affiliations

Dr. Mark Hlatky, Dr. Mark Hlatky, MD, Dr. M Hlatky, Dr. Mark A. Hlatky